Indirect and direct anticoagulants predominantly inhibiting factor Xa
Synthetic or natural indirect and synthetic direct factor Xa inhibitors with specific
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Synthetic or natural indirect and synthetic direct factor Xa inhibitors with specific
efficacy of dabigatran etexilate for the treatment of deep-vein thrombosis and pulmonary embolism, primary and secondary prevention of venous thromboembolism, prevention of stroke and systemic embolism in patients with
left atrial appendage (LAA) dysfunction using tissue Doppler mitral annular systolic velocity in acute embolic stroke young patients with sinus rhythm. Methods : Transthoracic (TTE) and transesophageal echocardiograhy…
being asymptomatic to shortness of breath, congestive heart failure, cerebral vascular accidents or other embolic events, chest pain, active endocarditis infection. Enlargement of the aneurysm may lead to aortic
pericardial fluid with a mobile fibrin strands, lack of signs of acute pulmonary embolism, normal sized ascending aorta without dissection were found. A chest computed tomography revealed fluid
contributed to that substandard care (CEMACE, 2011). Of the women who died of pulmonary embolism, 79% of them had identifiable VTE risk factors (RCOG, 2009). Engagement with VTE prophylaxis requires
this theme, Dr Macdonald from the UK reviews the role of filter design in embolic protection for carotid artery stenting [8]. There are reviews on structural cardiac interventions
discussion of how best to approach complex coronary and peripheral interventions [8]. Should embolic protection devices be utilized during interventions on patients with criticial limb ischemia? How is proximal left
dabigatran etexilate is a new oral direct thrombin inhibitor to prevent stroke and systemic embolization. Dabigatran has few drug or food interactions, and has predictable pharmacokinetics that obviate the need
treatment of both patients with deep vein thrombosis and those with hemodynamically stable pulmonary embolism. The oral administration of rivaroxaban (15 mg twice a day for the first 3 weeks
furthermore, there is no effect on pulmonary embolism, VTE‑related death and death from any other cause, and significant enhancement of hemorrhages
form of surgical pulmonary endarterectomy. There is a strong link between pulmonary embolism and the development of CTEPH. Although initially felt to be a rare complication, this position has been ... that up to 8.8% of…
advantageous to traditional anticoagulants in terms of bleeding in AF and in terms of embolisms after orthopaedic surgery. Ongoing Phase III clinical trials for thromboembolic event prophylaxis and treatment
pediatric renal trauma were recorded and evaluated. The two groups: the transcatheter arterial embolization (TAE) group and the non-TAE group were compared for clinical features and laboratory data. Eighteen
trauma, swelling, joint immobility, but these can lead to life threatening conditions like thrombosis, embolism, variety of infections and so on. Aim: The main objective of the study ... revealed that out of 100…
Rivaroxaban is a direct factor Xa inhibitor that can be administered orally
toxicology . Since steatohepatitis did not have any complication such as fat embolism, it can be concluded that the combination of steatohepatitis and cardiovascular disorder led to sudden unexpected death
Results: Follow-up ranged between 2 and 24 months. Complications included two asymptomatic pulmonary embolism, seven leakages (intradiscal, endospecal, vascular), three motor deficits requiring in one, surgical…
For authors and organisers
Find the right journal for your paper and submit your manuscript.